To investigate the impact of circDTL, hsa-miR-330-3p, and CCL20 on COPD cell function, we established a COPD cell model and treated BEAS-2B cells with 1%, 5%, and 7.5% cigarette extract (CSE) for 24 and 48 h. Here, CCL20 is linked to chronic obstructive pulmonary disease.